| 1 | fetal | 9,862 |
| 2 | foetal | 550 |
| 3 | maternal-fetal | 176 |
| 4 | cashmere | 27 |
| 5 | fetal-maternal | 24 |
| 6 | materno-fetal | 21 |
| 7 | maternal/fetal | 17 |
| 8 | pr-positive | 10 |
| 9 | preretinal | 10 |
| 10 | estrogen-stimulated | 8 |
| 11 | 3rd-order | 6 |
| 12 | area-specific | 6 |
| 13 | statural | 6 |
| 14 | acrobio | 4 |
| 15 | td-affected | 4 |
| 16 | 26-gene | 3 |
| 17 | cox-mediated | 3 |
| 18 | ovular | 3 |
| 19 | smartinhaler | 3 |
| 20 | 5,698 | 2 |
| 21 | imagery-induced | 2 |
| 22 | interconverting | 2 |
| 23 | testing-specific | 2 |
| 24 | trunk-arm | 2 |
| 25 | upper-left | 2 |
| 26 | weaning-induced | 2 |
| 27 | 14-3-3ζ-induced | 1 |
| 28 | anti-ny-eso-1 | 1 |
| 29 | crispr-based | 1 |
| 30 | development-maternal-fetal | 1 |
| 31 | dimethy | 1 |
| 32 | effects.physical | 1 |
| 33 | face/ffr | 1 |
| 34 | fibro-nodular | 1 |
| 35 | growth-and | 1 |
| 36 | pioglitazoneau | 1 |
| 37 | placental-myometrial | 1 |
| 38 | pth-resistant | 1 |
| 39 | sympathicotonic | 1 |
| 1 | 14-3-3ζ-induced | 1 |
| 2 | 26-gene | 3 |
| 3 | 3rd-order | 6 |
| 4 | 5,698 | 2 |
| 5 | acrobio | 4 |
| 6 | anti-ny-eso-1 | 1 |
| 7 | area-specific | 6 |
| 8 | cashmere | 27 |
| 9 | cox-mediated | 3 |
| 10 | crispr-based | 1 |
| 11 | development-maternal-fetal | 1 |
| 12 | dimethy | 1 |
| 13 | effects.physical | 1 |
| 14 | estrogen-stimulated | 8 |
| 15 | face/ffr | 1 |
| 16 | fetal | 9,862 |
| 17 | fetal-maternal | 24 |
| 18 | fibro-nodular | 1 |
| 19 | foetal | 550 |
| 20 | growth-and | 1 |
| 21 | imagery-induced | 2 |
| 22 | interconverting | 2 |
| 23 | maternal-fetal | 176 |
| 24 | maternal/fetal | 17 |
| 25 | materno-fetal | 21 |
| 26 | ovular | 3 |
| 27 | pioglitazoneau | 1 |
| 28 | placental-myometrial | 1 |
| 29 | pr-positive | 10 |
| 30 | preretinal | 10 |
| 31 | pth-resistant | 1 |
| 32 | smartinhaler | 3 |
| 33 | statural | 6 |
| 34 | sympathicotonic | 1 |
| 35 | td-affected | 4 |
| 36 | testing-specific | 2 |
| 37 | trunk-arm | 2 |
| 38 | upper-left | 2 |
| 39 | weaning-induced | 2 |
| 1 | anti-ny-eso-1 | 1 |
| 2 | 5,698 | 2 |
| 3 | area-specific | 6 |
| 4 | testing-specific | 2 |
| 5 | sympathicotonic | 1 |
| 6 | weaning-induced | 2 |
| 7 | imagery-induced | 2 |
| 8 | 14-3-3ζ-induced | 1 |
| 9 | crispr-based | 1 |
| 10 | cox-mediated | 3 |
| 11 | estrogen-stimulated | 8 |
| 12 | td-affected | 4 |
| 13 | growth-and | 1 |
| 14 | 26-gene | 3 |
| 15 | cashmere | 27 |
| 16 | pr-positive | 10 |
| 17 | interconverting | 2 |
| 18 | effects.physical | 1 |
| 19 | placental-myometrial | 1 |
| 20 | preretinal | 10 |
| 21 | fetal-maternal | 24 |
| 22 | statural | 6 |
| 23 | fetal | 9,862 |
| 24 | maternal-fetal | 176 |
| 25 | development-maternal-fetal | 1 |
| 26 | materno-fetal | 21 |
| 27 | maternal/fetal | 17 |
| 28 | foetal | 550 |
| 29 | trunk-arm | 2 |
| 30 | acrobio | 4 |
| 31 | fibro-nodular | 1 |
| 32 | ovular | 3 |
| 33 | 3rd-order | 6 |
| 34 | smartinhaler | 3 |
| 35 | face/ffr | 1 |
| 36 | upper-left | 2 |
| 37 | pth-resistant | 1 |
| 38 | pioglitazoneau | 1 |
| 39 | dimethy | 1 |